sk&f 104856 has been researched along with terazosin in 2 studies
| Studies (sk&f 104856) | Trials (sk&f 104856) | Recent Studies (post-2010) (sk&f 104856) | Studies (terazosin) | Trials (terazosin) | Recent Studies (post-2010) (terazosin) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 658 | 173 | 104 |
| Protein | Taxonomy | sk&f 104856 (IC50) | terazosin (IC50) |
|---|---|---|---|
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.428 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 6.042 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.011 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.005 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
| Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
1 review(s) available for sk&f 104856 and terazosin
| Article | Year |
|---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
1 other study(ies) available for sk&f 104856 and terazosin
| Article | Year |
|---|---|
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |